These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3530781)

  • 1. The effect of bucindolol on the airway function of asthmatics.
    Ruffin RE; Crockett AJ; Alpers JH
    Eur J Clin Pharmacol; 1986; 30(5):559-65. PubMed ID: 3530781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of an oral potassium channel activator, BRL 38227, on airway function and responsiveness in asthmatic patients: comparison with oral salbutamol.
    Kidney JC; Fuller RW; Worsdell YM; Lavender EA; Chung KF; Barnes PJ
    Thorax; 1993 Feb; 48(2):130-3. PubMed ID: 8493625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preventive effects of inhaled formoterol and salbutamol on histamine-induced bronchoconstriction--a placebo-controlled study.
    Sovijärvi AR; Reinikainen K; Freudenthal Y; Andersson P; Riska H
    Respiration; 1992; 59(5):279-82. PubMed ID: 1488561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
    Cass LM; Gunawardena KA; Macmahon MM; Bye A
    Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and functional responses to salbutamol inhaled via different devices in asthmatic patients with induced bronchoconstriction.
    Lavorini F; Geri P; Luperini M; Maluccio NM; Mariani L; Marmai C; Pistolesi M; Fontana GA
    Br J Clin Pharmacol; 2004 Nov; 58(5):512-20. PubMed ID: 15521899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regular inhaled salbutamol and airway responsiveness to allergen.
    Cockcroft DW; McParland CP; Britto SA; Swystun VA; Rutherford BC
    Lancet; 1993 Oct; 342(8875):833-7. PubMed ID: 8104272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase IIa proof-of-concept, placebo-controlled, randomized, double-blind, crossover, single-dose clinical trial of a new class of bronchodilator for acute asthma.
    Swystun V; Green FHY; Dennis JH; Rampakakis E; Lalli G; Fadayomi M; Chiu A; Shrestha G; El Shahat SG; Nelson DE; El Mays TY; Pieron CA; Leigh R
    Trials; 2018 Jun; 19(1):321. PubMed ID: 29914544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Speed of onset of bronchodilator response to salbutamol inhaled via different devices in asthmatics: a bioassay based on functional antagonism.
    Lavorini F; Geri P; Mariani L; Marmai C; Maluccio NM; Pistolesi M; Fontana GA
    Br J Clin Pharmacol; 2006 Oct; 62(4):403-11. PubMed ID: 16995861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Area under the maximum expiratory flow-volume curve--a sensitive parameter in the evaluation of airway patency.
    Zapletal A; Hladíková M; Chalupová J; Svobodová T; Vávrová V
    Respiration; 2008; 75(1):40-7. PubMed ID: 17299253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchodilator and bronchoprotective effects of salmeterol in young patients with asthma.
    Simons FE; Soni NR; Watson WT; Becker AB
    J Allergy Clin Immunol; 1992 Nov; 90(5):840-6. PubMed ID: 1358932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of ipratropium bromide on histamine-induced bronchoconstriction in subjects with chronic airway obstruction].
    Nannini LJ
    Medicina (B Aires); 2001; 61(3):262-6. PubMed ID: 11474870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of single doses of S-salbutamol, R-salbutamol, racemic salbutamol, and placebo on the airway response to methacholine.
    Cockcroft DW; Swystun VA
    Thorax; 1997 Oct; 52(10):845-8. PubMed ID: 9404369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.
    Bel EH; Zwinderman AH; Timmers MC; Dijkman JH; Sterk PJ
    Thorax; 1991 Jan; 46(1):9-14. PubMed ID: 1871705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bronchodilator effect of caffeine in adult asthmatics.
    Bukowskyj M; Nakatsu K
    Am Rev Respir Dis; 1987 Jan; 135(1):173-5. PubMed ID: 3541714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of bronchodilatation after spontaneous recovery from a histamine challenge in asthmatic children.
    Merkus PJ; Rooda HM; van Essen-Zandvliet EE; Duiverman EJ; Quanjer PH; Kerrebijn KF
    Thorax; 1992 May; 47(5):355-9. PubMed ID: 1609378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of airway calibre on lung delivery of nebulised salbutamol.
    Lipworth BJ; Clark DJ
    Thorax; 1997 Dec; 52(12):1036-9. PubMed ID: 9516895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of the bronchodilation response to salbutamol on histamine-induced bronchoconstriction.
    Koskela HO; Kiviniemi V; Purokivi MK; Taivainen AH; Tukiainen HO
    Respir Med; 2006 Oct; 100(10):1760-6. PubMed ID: 16563715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.
    Taylor DR; Sears MR; Herbison GP; Flannery EM; Print CG; Lake DC; Yates DM; Lucas MK; Li Q
    Thorax; 1993 Feb; 48(2):134-8. PubMed ID: 8493626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.
    Lötvall J; Ankerst J
    Respir Med; 2008 Mar; 102(3):449-56. PubMed ID: 18023335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.